A slowdown of hepatitis C diagnosis in high-prevalence groups and with decentralized diagnostic strategies during the COVID-19 pandemic

the COVID-19 pandemic has had a major impact on hepatitis C virus (HCV) diagnosis by hindering the path to elimination. Albeit, in an uneven manner, depending on the risk group and diagnostic strategy. the requests of antibodies/RNA by venipuncture at hospitals and Primary Care centers (centralized)...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Revista española de enfermedades digestivas 2023-04, Vol.115 (4), p.175-180
Hauptverfasser:	Morales-Arráez, Dalia, Benítez-Zafra, Federica, Díaz-Flores, Felicitas, Medina-Alonso, María Jesús, Santiago, Luz Goretti, Pérez-Pérez, Víctor, Gutiérrez-Nicolás, Fernando, Hernández-Guerra, Manuel
Format:	Artikel
Sprache:	eng
Schlagworte:	COVID-19 - epidemiology COVID-19 Testing Delayed Diagnosis Female Hepacivirus - genetics Hepatitis C - diagnosis Hepatitis C - drug therapy Hepatitis C - epidemiology Humans Male Pandemics Prevalence
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!